Chinese General Practice ›› 2023, Vol. 26 ›› Issue (29): 3640-3644.DOI: 10.12114/j.issn.1007-9572.2023.0164
• Original Research • Previous Articles Next Articles
Received:
2023-03-06
Revised:
2023-05-15
Published:
2023-10-15
Online:
2023-05-18
Contact:
JI Xunming, WANG Yuan
通讯作者:
吉训明, 王媛
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0164
组别 | 人数 | 年龄(岁) | BMI(kg/m2) | 收缩压(mmHg) | 舒张压(mmHg) | 心率(次/min) |
---|---|---|---|---|---|---|
对照组 | 20 | 36.1±6.0 | 23.8±3.5 | 126±12 | 83±10 | 79.0±9.8 |
试验组 | 20 | 36.1±6.2 | 24.5±3.2 | 121±10 | 81±9 | 84.6±8.7 |
t值 | <0.001 | 0.637 | 1.495 | 0.666 | 1.908 | |
P值 | >0.999 | 0.528 | 0.143 | 0.509 | 0.064 |
Table 1 Comparison of baseline data between the two groups
组别 | 人数 | 年龄(岁) | BMI(kg/m2) | 收缩压(mmHg) | 舒张压(mmHg) | 心率(次/min) |
---|---|---|---|---|---|---|
对照组 | 20 | 36.1±6.0 | 23.8±3.5 | 126±12 | 83±10 | 79.0±9.8 |
试验组 | 20 | 36.1±6.2 | 24.5±3.2 | 121±10 | 81±9 | 84.6±8.7 |
t值 | <0.001 | 0.637 | 1.495 | 0.666 | 1.908 | |
P值 | >0.999 | 0.528 | 0.143 | 0.509 | 0.064 |
组别 | 人数 | AMS发生率〔名(%)〕 | LLS总分(分) |
---|---|---|---|
对照组 | 20 | 10(50) | 2.30±1.89 |
试验组 | 20 | 2(10) | 1.30±0.98 |
χ2(t)值 | 7.619 | 2.097a | |
P值 | 0.006 | 0.045 |
Table 2 Comparison of AMS incidence and LLS between the two groups
组别 | 人数 | AMS发生率〔名(%)〕 | LLS总分(分) |
---|---|---|---|
对照组 | 20 | 10(50) | 2.30±1.89 |
试验组 | 20 | 2(10) | 1.30±0.98 |
χ2(t)值 | 7.619 | 2.097a | |
P值 | 0.006 | 0.045 |
组别 | 人数 | SpO2(%) | ScO2(%) | ICP(mmH2O) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
基线 | 急性高原低氧环境模拟前 | 急性高原低氧环境模拟6 h后 | 基线 | 急性高原低氧环境模拟前 | 急性高原低氧环境模拟6 h后 | 基线 | 急性高原低氧环境模拟前 | 急性高原低氧环境模拟6 h后 | ||
对照组 | 20 | 98.75±1.07 | 98.55±1.10 | 85.45±6.58ab | 67.25±2.71 | 67.30±3.20 | 64.10±3.37ab | 119.7±27.4 | 112.0±28.3 | 136.6±41.6b |
试验组 | 20 | 98.30±1.17 | 98.50±0.95 | 89.20±4.43ab | 66.80±2.28 | 67.75±2.95 | 64.05±2.95ab | 132.2±35.1 | 111.6±27.8 | 114.0±31.3 |
t值 | 1.267 | 0.154 | 2.114 | 0.567 | 0.462 | 0.050 | 1.259 | 0.043 | 1.939 | |
P值 | 0.213 | 0.878 | 0.041 | 0.574 | 0.646 | 0.960 | 0.216 | 0.966 | 0.060 |
Table 3 Comparison of tissue oxygen saturation and intracranial pressure between the two groups
组别 | 人数 | SpO2(%) | ScO2(%) | ICP(mmH2O) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
基线 | 急性高原低氧环境模拟前 | 急性高原低氧环境模拟6 h后 | 基线 | 急性高原低氧环境模拟前 | 急性高原低氧环境模拟6 h后 | 基线 | 急性高原低氧环境模拟前 | 急性高原低氧环境模拟6 h后 | ||
对照组 | 20 | 98.75±1.07 | 98.55±1.10 | 85.45±6.58ab | 67.25±2.71 | 67.30±3.20 | 64.10±3.37ab | 119.7±27.4 | 112.0±28.3 | 136.6±41.6b |
试验组 | 20 | 98.30±1.17 | 98.50±0.95 | 89.20±4.43ab | 66.80±2.28 | 67.75±2.95 | 64.05±2.95ab | 132.2±35.1 | 111.6±27.8 | 114.0±31.3 |
t值 | 1.267 | 0.154 | 2.114 | 0.567 | 0.462 | 0.050 | 1.259 | 0.043 | 1.939 | |
P值 | 0.213 | 0.878 | 0.041 | 0.574 | 0.646 | 0.960 | 0.216 | 0.966 | 0.060 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] | |
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[1] | ZHANG Dongli, SHEN Chong, ZHANG Weichuan, CHEN Haibin, ZHAO Jianjun. Efficacy and Safety of Programmed Death-1/Programmed Death-1 Ligand Inhibitors in the Treatment of Renal Cell Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3815-3822. |
[2] | LIU Ruifang, XU Fangxing, LIU Tongku, ZHOU Yujie, WU Xiaofan. Evaluation of the Efficacy and Safety of "Crowbar Effect" Technique to Facilitate Balloon Crossing Resistant Chronic Total Occlusions Lesions [J]. Chinese General Practice, 2023, 26(29): 3683-3688. |
[3] | LIU Minghao, WANG Pan, GAO Lijian, XU Shuqing, WANG Huanhuan, ZHAO Guangxian, CHEN Jue, QIAO Shubin, XU Bo, YUAN Jinqing. Feasibility, Safety and Timing of Secondary Percutaneous Coronary Intervention via Distal Transradial Artery Approach [J]. Chinese General Practice, 2023, 26(27): 3366-3372. |
[4] | LU Bin, XIANG Chong, YUAN Xuesong, CAI Gaojun, WEI Wenfeng, YAN Yongmin. Effectiveness, Safety and Satisfaction of Distal Transradial Artery Approach in Cerebral Angiography [J]. Chinese General Practice, 2023, 26(27): 3378-3382. |
[5] | ZHANG Yong, CAI Xiang, NING Feifei, LIANG Xiao, GUO Ning. Comparative Study of the Efficacy and Safety of Sacubitril/Valsartan and Dapagliflozin in the Treatment of Dilated Cardiomyopathy with Low Blood Pressure [J]. Chinese General Practice, 2023, 26(23): 2912-2917. |
[6] | CHEN Lulu, ZHANG Liping, LI Jingwen, DONG Wenjie, WU Xin'ai. Clinical Effect and Safety of PD-1 Inhibitors plus Fruquintinib as Later-line Treatment for Metastatic Colorectal Cancer [J]. Chinese General Practice, 2023, 26(18): 2262-2267. |
[7] | ZHANG Kang, JI Wenshuai, KONG Xinxin, DU Chen, XIE Kai, WANG Haifeng. Predictive Efficacies of SOFA Score, CURB-65 Score and PSI Score for 28-day Mortality in Patients with Severe Pneumonia: a Comparative Study [J]. Chinese General Practice, 2023, 26(18): 2217-2222. |
[8] | ZHANG Lina, WANG Yan, ZHANG Kanghuai, LI Youjia. Clinical Research Progress of Tirzepatide: a New Hypoglycemic Agent [J]. Chinese General Practice, 2023, 26(15): 1902-1908. |
[9] | WANG Lingxiao, DONG Rongna, ZHOU Bing, GUO Lina, LI Jing. Analysis of the Effect of Human-computer Interaction Intelligent Management on Blood Glucose Control in New-onset Type 2 Diabetes Mellitus Patients [J]. Chinese General Practice, 2023, 26(15): 1817-1823. |
[10] | LI Jiaqing, YANG Qing, YUAN Dunlu, HUANG Jingjing, CHANG Qing, NIE Jingwen, ZHOU Zhu, LI Qing. Effectiveness and Safety of Roxadustat for Renal Anemia in Dialysis-dependent Chronic Kidney Disease: a Meta-analysis [J]. Chinese General Practice, 2023, 26(06): 704-710. |
[11] | SONG Pingan, CHEN Xiaoliang, YAO Yuan, GAO Jin, YANG Yang, CUI Hongchun, ZHANG Yi. Efficacy and Safety of PD-1 Inhibitors Monotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(02): 241-247. |
[12] | GAO Hui, LIU Suzhen, LI Hang. The Safety Support and Willingness of Providing Home Care Services by Medical Staff of Primary Health Care Institutions [J]. Chinese General Practice, 2022, 25(34): 4326-4331. |
[13] | LU Chunjian, LIU Wei, LIN Shaoxia, ZHU Yanxian, PI Min. Efficacy and Safety of the Five Commonly Used External Therapies of TCM Combined with Conventional Western Medicine in Treating Diabetic Peripheral Neuropathy: a Bayesian Network Meta-analysis [J]. Chinese General Practice, 2022, 25(33): 4106-4116. |
[14] | JIA Dongxia, PENG Junchen, LIU Sitai, LI Lan, ZHENG Hang, HOU Liangping, YANG Xianzheng, HUANG Qiangpei, GAO Chao. Meta Analysis of the Efficacy and Safety of Rennin-angiotensin-aldosterone System Iinhibitors in Patients with COVID-19 Associated with Hypertension [J]. Chinese General Practice, 2022, 25(33): 4117-4122. |
[15] | LIN Xiaohong, SHI Xinping, WANG Minghang, YANG Jiang, LI Suyun, LI Jiansheng. Duration of Yifei Moxibustion with Clinical Efficacy in COPD: Effectiveness Improvement Study and Applicability Analysis [J]. Chinese General Practice, 2022, 25(33): 4145-4152. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||